Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358

التفاصيل البيبلوغرافية
العنوان: Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358
المؤلفون: Ibrahima Soumaoro, Ricardo Zwirtes, Ragini R. Kudchadkar, Shailender Bhatia, Shrujal S. Baxi, Janis M. Taube, Tian Chen, Céleste Lebbé, Robert L. Ferris, Asim Amin, William H. Sharfman, Jean-Pierre Delord, Christine H. Chung, Z. Alexander Cao, Suzanne L. Topalian, Michi M. Shinohara, Uwe M. Martens, Julie E. Stein, Paul Nghiem
المصدر: Journal of Clinical Oncology. 36:9505-9505
بيانات النشر: American Society of Clinical Oncology (ASCO), 2018.
سنة النشر: 2018
مصطلحات موضوعية: Cancer Research, integumentary system, biology, business.industry, Merkel cell carcinoma, medicine.medical_treatment, virus diseases, food and beverages, Merkel cell polyomavirus, biology.organism_classification, medicine.disease, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Oncology, 030220 oncology & carcinogenesis, Cancer research, Medicine, In patient, Skin cancer, Nivolumab, business, Neoadjuvant therapy
الوصف: 9505Background: MCC is a rare, aggressive skin cancer commonly associated with the oncogenic Merkel cell polyomavirus (MCPyV). The PD-1/PD-L1 immunosuppressive pathway is often upregulated in MCC, ...
تدمد: 1527-7755
0732-183X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f70ad60763a8f63cab9eb4570130ba75Test
https://doi.org/10.1200/jco.2018.36.15_suppl.9505Test
رقم الانضمام: edsair.doi...........f70ad60763a8f63cab9eb4570130ba75
قاعدة البيانات: OpenAIRE